OncoGenex planning follow-on

OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) said late Thursday it is planning a follow-on underwritten by Leerink; Stifel Nicolaus Weisel; Lazard; and William Blair. Further details were not disclosed. OncoGenex was up $1.23 to $17.43 on Thursday. ...